Breaking News
October 16, 2018 - New research identifies modifiable dementia risk factor in elderly people
October 16, 2018 - Zebrafish study uncovers molecular ‘brake’ that helps control eye lens development
October 16, 2018 - Overlapping copy number variations underlie autism and schizophrenia in Japanese patients
October 16, 2018 - Majority of Americans’ ancestry can be traced through existing DNA databases
October 16, 2018 - Patients coerced into mental health care less likely to perceive treatment as effective
October 16, 2018 - What you need to know about autism spectrum disorder
October 16, 2018 - Antidepressants can be used to treat Alzheimer’s disease
October 16, 2018 - Study uncovers important role of PRMT1 in dilated cardiomyopathy
October 16, 2018 - Nutritional quality of breakfast linked to cardiovascular and metabolic risk factors in children
October 16, 2018 - Study uses novel approach to investigate genetic origins of mental illnesses
October 16, 2018 - Scientists develop dual anthrax-plague vaccine
October 16, 2018 - Poor Outcomes for Hispanic Infants With Congenital Heart Dz
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - UA professor receives NSF grant to develop antifouling materials for medical implants
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
October 16, 2018 - Adults with ADHD not constrained in creativity
October 16, 2018 - Raising visibility for people and students with chronic illness and disability
October 16, 2018 - Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis
October 16, 2018 - Only 59% of young adults undergoing surgery are fluid responsive
October 16, 2018 - Research points to potential new treatment for hearing loss
October 16, 2018 - MDI Biological Laboratory receives $1.2 million SEPA grant to promote data literacy
October 16, 2018 - Vast majority of dementia cases may arise from spontaneous genetic errors
October 16, 2018 - New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases
October 16, 2018 - Study identifies molecular switch that controls fate of milk-producing breast cells
October 16, 2018 - Research shows diet has little influence on precursor to gout
October 16, 2018 - “Without Dr. Shumway doing his miracle work, three generations would not be here”: A Stanford heart transplant patient’s story
October 16, 2018 - Non-invasive brain stimulation sheds light on neurobiology underlying implicit bias
October 16, 2018 - Researchers demonstrate integrated technique to control production of cell therapeutics
October 16, 2018 - Breast tomosynthesis detects 34% more tumors than traditional mammography
October 16, 2018 - Rhode Island Hospital, Brown receive $800,000 grant to keep up fight against opioid epidemic
October 16, 2018 - UVA partners with health systems in AVIA network’s Medicaid Transformation Project
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
Women with high levels of anti-Müllerian hormone more likely to develop breast cancer

Women with high levels of anti-Müllerian hormone more likely to develop breast cancer

image_pdfDownload PDFimage_print

Having high levels of anti-Müllerian hormone (AMH) – a hormone that indicates the size of a woman’s ovarian reserve – before the menopause is associated with an increased risk of breast cancer, new research suggests.

In a major new study, leading scientists from NYU School of Medicine analysed blood samples from participants of ten cohort studies – including the Breast Cancer Now Generations Study at The Institute of Cancer Research, London – to examine the association of AMH levels with breast cancer risk.

The team examined blood samples from 5,957 premenopausal women from across the USA, the UK, Sweden and Italy, and found that those in the quartile with the highest levels of AMH in their blood were 60% more likely to develop breast cancer – both before and after menopause – when compared to those in the lowest quartile.

AMH is produced in the ovaries, and blood levels of the hormone are commonly incorporated into fertility tests. High levels of the hormone indicate a larger ovarian reserve – the capacity of the ovaries to produce viable egg cells. AMH is a marker of time to menopause, with levels peaking between the ages of 20-25, before declining and becoming undetectable after menopause.

Those with higher AMH levels for their age tend to reach menopause later in life, which is itself known to be a risk factor for breast cancer – but the study found that AMH levels predict breast cancer risk even for cases of breast cancer that occur before menopause.

The new analysis, published in the International Journal of Cancer, was led by Anne Zeleniuch-Jacquotte, Professor in the Departments of Population Health and Environmental Medicine at NYU School of Medicine, in collaboration with colleagues at The Institute of Cancer Research (ICR). The team examined AMH levels in participants’ blood samples that had been collected prospectively, comparing those in the highest quartile (top 25%) for AMH levels with those in the lowest quartile (bottom 25%).

In the analysis of 2,835 participants with breast cancer and 3,122 controls of similar ages, higher levels of AMH were found to be significantly associated with an increase in breast cancer risk, with the trend being seen across the entire range of AMH levels.

Results were adjusted for potential confounding risk factors for breast cancer such as BMI, how many children each woman had had, a family history of breast cancer, and the age at which each woman started her periods (menarche).

Looking at whether AMH levels were linked to risk of developing breast cancer of a certain subtype, the team found that those with the highest levels of AMH were 96% more likely to develop breast cancer that is susceptible to being driven by both estrogen and progesterone (ER+PR+ breast cancer) than those with the lowest levels of AMH.

The team is now examining whether incorporating AMH levels into current risk prediction models could lead to improved prediction of breast cancer risk in premenopausal women. It is hoped that being able to incorporate these hormone levels could help provide a more accurate indicator of risk for younger women, in particular to identify those at a higher risk of developing hormone-positive forms of breast cancer – providing women with more information on whether risk-reducing measures would be appropriate for them.

Study leader Anne Zeleniuch-Jacquotte, Professor in the Departments of Population Health and Environmental Medicine at NYU School of Medicine, said:

The link we found between anti-Müllerian hormone and breast cancer risk is interesting because few markers of risk in the blood have been identified for premenopausal women. Our study found a moderate risk increase, and we hope additional markers can now be found to help substantially improve individual risk prediction.

International collaborations like this one are critical to finding blood markers of breast cancer in younger women because individual studies often enroll too few young women to provide reliable results.”

Study co-author Anthony Swerdlow, Professor of Epidemiology at The Institute of Cancer Research, London, who leads the Breast Cancer Now Generations Study, said:

Our collaborative study gives the strongest evidence yet that anti-Müllerian hormone levels are linked with women’s risk of breast cancer. In future, anti-Müllerian hormone could be factored into new ways of predicting individual women’s risk of developing the disease.”

The causes of breast cancer are highly complex and not yet fully understood. Pooling together large datasets is key to understanding how the many different causes interact and affect breast cancer risk.”

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, which helped fund the research, said:

The discovery that high levels of anti-Müllerian hormone in the blood could indicate women at an increased risk of breast cancer is really promising. We now need to understand whether adding this blood test to current prediction tools could help give women a clearer picture of their risk, and identify those who could benefit from more frequent screening or preventive measures, such as tamoxifen.

Breast cancer risk is affected by a combination of our genes, lifestyle choices and events throughout life. With many contributing factors, such as pregnancy and menopause, relating to female sex hormones, it is vital that we continue to build our understanding of how these hormones affect women’s risk.

Whilst there are some things you can’t change, there are steps all women can take to lower their breast cancer risk, such as maintaining a healthy weight, reducing your alcohol intake and keeping physically active.”

The Breast Cancer Now Generations Study is a landmark prospective study of the causes of breast cancer that is following over 113,000 UK women for 40 years. With more women being diagnosed with breast cancer than ever before, the Study – which is based at The Institute of Cancer Research (ICR) – continues to investigate the genetic, lifestyle and environmental factors that may change a woman’s risk of developing breast cancer.

The Study has already led to a number of significant discoveries into the interlinked causes of breast cancer, including clarifying that women taking combined HRT are 2.7 times more likely to develop breast cancer than non-users, and that smoking is particularly associated with an increased risk of breast cancer among those who began smoking during adolescence.

Source:

https://breastcancernow.org/

Tagged with:

About author

Related Articles